Tumor rejection in syngeneic mice is believed to be the consequence of recognition of discrete tumor antigens by the host's immune system, predominantly via recognition of mutated or over-expressed "self" peptides displayed in the context of MHC-I molecules by cytotoxic (CD8+) T lymphocytes [1]. Here, CD8A is linked to neoplasm.